Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 6/20 | 0.47 |
| ▸ | CA7 | P43166 | 3/20 | 0.47 |
| ▸ | CA4 | P22748 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 8/20 | 0.45 |
| ▸ | CA1 | P00915 | 7/20 | 0.45 |
| ▸ | CA9 | Q16790 | 5/20 | 0.45 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24236732 | 0.83 | MEN1 (0.51) | RAB9ACA12CA7CA4MEN1 | |
| SCHEMBL24236730 | 0.83 | MEN1 (0.52) | RAB9ACA12CA7CA4MEN1 | |
| SCHEMBL24236718 | 0.83 | HTT (0.46) | RAB9ACA12CA7CA4MEN1 | |
| SCHEMBL24236742 | 0.82 | RXFP1 (0.49) | RAB9ACA12MEN1KMT2AALDH1A1 | |
| SCHEMBL23917917 | 0.81 | CA1 (0.47) | RAB9ACA12CA4MEN1KMT2A | |
| SCHEMBL24236735 | 0.80 | MEN1 (0.57) | RAB9ACA12CA7CA4MEN1 | |
| SCHEMBL24236737 | 0.79 | RXFP1 (0.44) | RAB9ACA12CA7CA4MEN1 | |
| SCHEMBL24236769 | 0.78 | MEN1 (0.48) | RAB9ACA12CA7CA4MEN1 | |
| SCHEMBL23917901 | 0.77 | CA1 (0.44) | RAB9ACA12CA4MEN1KMT2A | |
| SCHEMBL9741869 | 0.74 | CA9 (0.66) | RAB9ACA12CA7CA4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220033585-A1 | DIAMINE COMPOUND, AND POLYIMIDE PRECURSOR AND POLYIMIDE FILM USING SAME | LG CHEM, LTD. (KR) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220033585-A1 | DIAMINE COMPOUND, AND POLYIMIDE PRECURSOR AND POLYIMIDE FILM USING SAME | DDC, PUF60, PARG | RAB9A 1969/4885CA12 1733/4885CA7 3055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.